Max Donley
Equibles does not estimate personal net worth.
About Max Donley
Max Donley was last confirmed as COO at Aurinia Pharmaceuticals Inc. (AUPH) in a filing dated April 17, 2025. The proxy statement of Aurinia Pharmaceuticals Inc. reports total compensation of $2,514,527 for Max Donley in fiscal 2024, including a base salary of $539,321. Disclosed compensation is on record for 7 fiscal years.
Affiliation history
-
Start not stated–2025-04-17
Last confirmed by a filing; no departure on record
-
Aurinia Pharmaceuticals Inc. (AUPH)
Proxy statement
Start not stated–2024-05-03
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | $539,321 | $2,514,527 |
| 2023 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | $513,640 | $4,558,086 |
| 2022 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | $493,885 | $3,312,497 |
| 2021 | Aurinia Pharmaceuticals Inc. (AUPH) | EVP, Operations and Strategy | $448,986 | $730,638 |
| 2020 | Aurinia Pharmaceuticals Inc. (AUPH) | EVP, Operations and Strategy | $383,320 | $3,338,217 |
| 2019 | Aurinia Pharmaceuticals Inc. (AUPH) | EVP, Operations and Strategy | $168,299 | $945,903 |
| 2018 | Aurinia Pharmaceuticals Inc. (AUPH) | EVP, Operations and Strategy | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.